Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot# NCI R03L1: A Phase 2 Study of OSI 774 (IND# 63383) in Combination with Celecoxib (Celebrex, Pharmacia) as Second-Line Therapy in Advanced Non-Small Cell Lung Cancer (NCI prot# 5416) (Rush prot# Lung 2002-1)
Patel, Jyoti D
(PD/PI)
Flaum, Lisa Ellen
(Other)
Frankfurt, Olga
(Other)
Zakarija, Anaadriana
(Other)
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
3/22/04
→
1/1/08
Funding
Rush University Medical Center
(PRESPENDING)
Pfizer Inc.
(PRESPENDING)
View all
View less